» Articles » PMID: 33444197

Impact of Reimbursement Rates on the Length of Stay in Tertiary Public Hospitals: a Retrospective Cohort Study in Shenzhen, China

Overview
Journal BMJ Open
Specialty General Medicine
Date 2021 Jan 14
PMID 33444197
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the association between reimbursement rates and the length of stay (LOS).

Design: A retrospective cohort study.

Setting: The study was conducted in Shenzhen, China by using health administrative database from 1 January 2015 to 31 December 2017.

Participants: 6583 patients with acute myocardial infarction (AMI), 12 395 patients with pneumonia and 10 485 patients who received percutaneous coronary intervention (PCI) surgery.

Measures: The reimbursement rate was defined as one minus the ratio of out-of-pocket to the total expenditure, multiplied by 100%. The outcome of interest was the LOS. Multilevel negative binomial regression models were constructed to control for patient-level and hospital-level characteristics, and the marginal effect was reported when non-linear terms were available.

Results: Each additional unit of the reimbursement rate was associated with an average of an additional increase of 0.019 (95% CI, 0.015 to 0.023), 0.011 (95% CI, 0.009 to 0.014) and 0.013 (95% CI, 0.010 to 0.016) in the LOS for inpatients with AMI, pneumonia and PCI surgery, respectively. Adding the interaction term between the reimbursement rate and in-hospital survival, the average marginal effects for the deceased inpatients with AMI and PCI surgery were 0.044 (95% CI, 0.031 to 0.058) and 0.034 (95% CI, 0.017 to 0.051), respectively. However, there was no evidence that higher reimbursement rates prolonged the LOS of the patients who died of pneumonia (95% CI, -0.013 to 0.016).

Conclusions: The findings indicate that the higher the reimbursement rate, the longer the LOS; and implementing dynamic supervision and improving the service capabilities of primary healthcare providers may be an important strategy for reducing moral hazard in low-income and middle-income countries including China.

Citing Articles

Burden of In-Hospital Admissions and Outcomes of Thoracic Outlet Compression Syndrome in the United States From 2010 to 2021.

Uwumiro F, Ayo-Farai O, Uduigwome E, Nwebonyi S, Amadi E, Faniyi O Cureus. 2024; 16(10):e71608.

PMID: 39553137 PMC: 11565632. DOI: 10.7759/cureus.71608.

References
1.
Chen Y, Schweitzer S . Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region. Value Health. 2008; 11 Suppl 1:S124-9. DOI: 10.1111/j.1524-4733.2008.00376.x. View

2.
Jakovljevic M, Milovanovic O . Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS. Front Public Health. 2015; 3:65. PMC: 4407477. DOI: 10.3389/fpubh.2015.00065. View

3.
Finkelstein A, Taubman S, Wright B, Bernstein M, Gruber J, Newhouse J . THE OREGON HEALTH INSURANCE EXPERIMENT: EVIDENCE FROM THE FIRST YEAR. Q J Econ. 2013; 127(3):1057-1106. PMC: 3535298. DOI: 10.1093/qje/qjs020. View

4.
Shen M, He W, Yeoh E, Wu Y . The association between an increased reimbursement cap for chronic disease coverage and healthcare utilization in China: an interrupted time series study. Health Policy Plan. 2020; 35(8):1029-1038. DOI: 10.1093/heapol/czaa087. View

5.
Einav L, Finkelstein A . Moral Hazard in Health Insurance: What We Know and How We Know It. J Eur Econ Assoc. 2018; 16(4):957-982. PMC: 6128379. DOI: 10.1093/jeea/jvy017. View